Background—Percutaneous transcatheter closure of patent foramen ovale (PFO) is used as
an alternative to surgery or long-term anticoagulation for the treatment of patients with …

OBJECTIVES We report the largest and the longest follow-up to date of patients who
underwent transcatheter patent foramen ovale (PFO) closure for paradoxical embolism …

Aims Interventional PFO closure has previously been reported to reduce the risk for
recurrent thromboembolic events. The aim of the present study was to evaluate three …

Objectives: We sought to assess the safety and clinical efficacy of patent foramen ovale
(PFO) closure under fluoroscopic guidance only, without intraprocedural echocardiography …

Objective: To compare the safety and efficacy of percutaneous closure of patent foramen
ovale (PFO) with the Amplatzer PFO occluder (Amplatzer) or the PFO STAR device (STAR) …

The purpose of this study was to assess the safety and feasibility of percutaneous
interventional closure of patent foramen ovale (PFO) with or without atrial septal aneurysm …

Background—Patients with a patent foramen ovale (PFO) and paradoxical embolism are at
risk for recurrent thromboembolic events. This study investigated the long-term risk of …

The long-term risk and risk factors for recurrent embolism after percutaneous closure of
patent foramen ovale (PFO) were investigated in 152 consecutive patients with presumed …

Background—Patients with ischemic stroke or transient ischemic attack presumably related
to patent foramen ovale (PFO) are at risk for recurrent cerebrovascular events. Differences in …

Objectives: To carry out long-term follow-up after percutaneous closure of patent foramen
ovale (PFO) in patients with cryptogenic stroke. Design: Prospective cohort study. Setting …